For many, the senses return as the infection fades. This matters because loss of smell, known as anosmia, and loss of taste are common COVID-19 symptoms.
“The patients who received the drug didn’t lose any sense of smell or taste.
But, to the researchers’ surprise, it brought a different type of benefit. It showed that the medication, called camostat mesylate, did little to lessen viral load. The study, which is available on a preprint site and has not yet been published in a peer-reviewed journal, ran from June 2020 to April 2021. The scientists, led by Joseph Vinetz, MD, an infectious diseases specialist, were interested to find out if an oral medication used to treat pancreatitis could reduce the viral load (the amount of virus in your body) of SARS-CoV-2 and improve symptoms in people newly diagnosed with COVID-19. Loss of smell and taste-a hallmark symptom of COVID-19-was not on the minds of a group of Yale School of Medicine researchers when they embarked on a study in the spring of 2020.
0 kommentar(er)
